This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Morgan, Elizabeth
| Item Type | Name |
|
Academic Article
|
Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody.
|
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
|
Concept
|
Lymphoma, Mantle-Cell
|
|
Concept
|
Lymphoma, B-Cell
|
|
Concept
|
Lymphoma, T-Cell, Cutaneous
|
|
Concept
|
Lymphoma, T-Cell
|
|
Concept
|
Lymphoma, B-Cell, Marginal Zone
|
|
Concept
|
Lymphoma, Large-Cell, Anaplastic
|
|
Academic Article
|
Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma.
|
|
Academic Article
|
Targeted inhibition of CD47-SIRPa requires Fc-Fc?R interactions to maximize activity in T-cell lymphomas.
|
|
Academic Article
|
Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma.
|
|
Academic Article
|
Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm.
|
|
Academic Article
|
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.
|
|
Academic Article
|
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
|
|
Academic Article
|
Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project.
|
|
Academic Article
|
Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.
|
|
Academic Article
|
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.
|
|
Academic Article
|
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.
|
|
Academic Article
|
Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.
|
|
Academic Article
|
PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.
|
|
Academic Article
|
LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
|
|
Concept
|
Enteropathy-Associated T-Cell Lymphoma
|